{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:39:18Z","timestamp":1792787958960,"version":"4.5.0"},"reference-count":0,"publisher":"American Society of Hematology","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasm driven by somatic variants in MAPK-encoding genes, most commonly BRAFV600E. The prognostic value of BRAFV600E in the peripheral blood of children with LCH has never been investigated in an international setting characterized by different approaches. To this aim, five centers from the European Consortium for Histiocytosis (ECHO) analyzed the peripheral blood of 226 children enrolled in, or managed according to, the LCH-IV protocol. We quantified BRAFV600E burden in different DNA sources at diagnosis and after 6 weeks of vinblastine\/prednisone and evaluated its association with 2-year event-free survival (EFS). At diagnosis, BRAFV600E positivity could be equally determined through circulating cell-free (ccf) or peripheral blood mononuclear cell (PBMC)-DNA in patients with multi-system (MS) LCH. In single-system (SS) LCH, analyzing both substrates improved diagnostic sensitivity. For each clinical subgroup at diagnosis, we identified BRAFV600E levels associated with inferior 2-year EFS: \u2265LOQ (0.1% for ccf-DNA, 0.01% for PBMC-DNA) in SS and MS risk-organ negative (RO-) groups; \u22651% (both ccf- and PBMC-DNA) in MS risk-organ positive (RO+) group. Notably, BRAFV600E burden was independently associated with inferior EFS in multivariable analysis (HR 2.05, 95%CI: 1.11-3.78 for BRAFV600E \u2265LOQ, p=0.022; HR 4.53, 95%CI: 2.34-8.79 for BRAFV600E\u22651%, p&amp;lt;0.001). After 6 weeks of vinblastine\/prednisone, decreasing BRAFV600E burden (&amp;lt;0.1% in ccf-DNA or &amp;lt;0.01% in PBMC-DNA) was significantly associated with higher 2-year EFS (p&amp;lt;0.001 and p=0.009). These findings provide a framework for refining risk-stratification in pediatric LCH through the incorporation of peripheral blood BRAFV600E testing into international prospective clinical trials.<\/jats:p>","DOI":"10.1182\/bloodadvances.2026021834","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:55:05Z","timestamp":1792785305000},"update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["A European study on blood mutation monitoring in children with BRAFV600E-positive Langerhans Cell Histiocytosis"],"prefix":"10.1182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8278-0463","authenticated-orcid":false,"given":"Paul","family":"Milne","sequence":"first","affiliation":[{"name":"Newcastle University, Newcastle, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9046-4786","authenticated-orcid":false,"given":"Linda","family":"Beneforti","sequence":"additional","affiliation":[{"name":"University of Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6429-5942","authenticated-orcid":false,"given":"Aurora","family":"Chinnici","sequence":"additional","affiliation":[{"name":"Meyer Children's Hospital IRCCS, Florence, Italy, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Coniglio","sequence":"additional","affiliation":[{"name":"Meyer Children's Hospital IRCCS, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4954-5744","authenticated-orcid":false,"given":"Francesco","family":"Pegoraro","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy., Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8106-8098","authenticated-orcid":false,"given":"Irene","family":"Trambusti","sequence":"additional","affiliation":[{"name":"Meyer Children's University Hospital, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"H\u00e9lias-Rodzewicz","sequence":"additional","affiliation":[{"name":"CHU Ambroise Par\u00e9, Boulogne-Billancourt, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6839-0322","authenticated-orcid":false,"given":"Raphaela","family":"Schwentner","sequence":"additional","affiliation":[{"name":"St. Anna Children's Cancer Research Institute, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-5998","authenticated-orcid":false,"given":"Philipp","family":"Ben Soussia-Weiss","sequence":"additional","affiliation":[{"name":"St. Anna Children's Cancer Research Institute, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasja Shireen","family":"Roozeboom","sequence":"additional","affiliation":[{"name":"Sanquin, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie Liam","family":"Macdonald","sequence":"additional","affiliation":[{"name":"Newcastle University, Newcastle Upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Pagan","sequence":"additional","affiliation":[{"name":"Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venetia","family":"Bigley","sequence":"additional","affiliation":[{"name":"Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Slater","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasanta","family":"Nanduri","sequence":"additional","affiliation":[{"name":"Watford General Hospital, Watford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Consuelo","family":"Corti","sequence":"additional","affiliation":[{"name":"Scientific Institute for Research and Healthcare (IRCCS) San Gerardo dei Tintori Foundation, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Todesco","sequence":"additional","affiliation":[{"name":"Padua University Hospital, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2642-1706","authenticated-orcid":false,"given":"Michele","family":"Tanturli","sequence":"additional","affiliation":[{"name":"Universit\u00e0 degli Studi di Firenze, Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6073-4466","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Emile","sequence":"additional","affiliation":[{"name":"Paris-Saclay University, Versailles SQY University, INSERM U981, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Ambroise-Par\u00e9 Hospital, Smart Imaging, Service de Pathologie, Boulogne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cor","family":"van den Bos","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4485-146X","authenticated-orcid":false,"given":"Jean","family":"Donadieu","sequence":"additional","affiliation":[{"name":"Hopital Trousseau, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6471-8423","authenticated-orcid":false,"given":"Milen","family":"Minkov","sequence":"additional","affiliation":[{"name":"Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0384-6370","authenticated-orcid":false,"given":"Sebastien","family":"Heritier","sequence":"additional","affiliation":[{"name":"APHP TROUSSEAU, PARIS, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2059-4814","authenticated-orcid":false,"given":"Caroline","family":"Hutter","sequence":"additional","affiliation":[{"name":"St. Anna Children's Hospital, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0563-4155","authenticated-orcid":false,"given":"Astrid G.S.","family":"van Halteren","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6585-9586","authenticated-orcid":false,"given":"Matthew","family":"Collin","sequence":"additional","affiliation":[{"name":"Newcastle University, Newcastle Upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6192-9812","authenticated-orcid":false,"given":"Elena","family":"Sieni","sequence":"additional","affiliation":[{"name":"Hematology-Oncology Department, Meyer Children's Hospital, Florence, Italy, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,10,23]]},"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/doi\/10.1182\/bloodadvances.2026021834\/2596839\/bloodadvances.2026021834.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/doi\/10.1182\/bloodadvances.2026021834\/2596839\/bloodadvances.2026021834.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:55:06Z","timestamp":1792785306000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/doi\/10.1182\/bloodadvances.2026021834\/571691\/A-European-study-on-blood-mutation-monitoring-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026021834","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"article-number":"bloodadvances.2026021834"}}